Preferentially Expressed Antigen in Melanoma (PRAME) is another CTA which has been shown to be highly upregulated in a number of different neoplasms[17]; interestingly, it has been suggested that the PRAME may antagonize retinoic acid receptor signalling, thereby conferring proliferative advantages to tumour cells[23]. Here, PRAME is linked to neoplasm.